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ABSTRACT For insight into the solvent structure around protein molecules and its role in phase transformations, we
investigate the thermodynamics of crystallization of the rhombohedral form of porcine insulin crystals. We determine the
temperature dependence of the solubility at varying concentration of the co-solvent acetone, Cac ¼ 0%, 5%, 10%, 15%, and
20%, and ﬁnd that, as a rule, the solubility of insulin increases as temperature increases. The enthalpy of crystallization, DHocryst,
undergoes a stepwise shift from ;20 kJ mol1 at Cac ¼ 0%, 5%, and 10% to ;55 kJ mol1 at Cac ¼ 15% and 20%. The
entropy change upon crystallization DSocryst is ;35 J mol
1 K1 for the ﬁrst three acetone concentrations, and drops to ;110
J mol1 K1 at Cac ¼ 15% and 20%. DSocryst[0 indicates release of solvent, mostly water, molecules structured around the
hydrophobic patches on the insulin molecules’ surface in the solution. As Cac increases to 15% and above, unstructured
acetone molecules apparently displace the waters and their contribution to DSocryst is minimal. This shifts DS
o
cryst to a negative
value close to the value expected for tying up of one insulin molecule from the solution. The accompanying increase in DHocryst
suggests that the water structured around the hydrophobic surface moieties has a minimal enthalpy effect, likely due to the
small size of these moieties. These ﬁndings provide values of the parameters needed to better control insulin crystallization,
elucidate the role of organic additives in the crystallization of proteins, and help us to understand the thermodynamics of the
hydrophobicity of protein molecules and other large molecules.
INTRODUCTION
Type 1 diabetes is a condition that affects about one million
Americans, and 0.3% of the world’s population. It occurs
when the pancreas produces little or no insulin, a hormone
essential for glucose metabolism. Insulin deﬁciency leads to
dangerously high blood sugar levels. Type 1 diabetes usually
affects young people, who are then dependent on an artiﬁcial
source of insulin for life (Brange, 1987).
Insulin is often administered through daily injections,
which can become an inconvenience to the patient, and can
be dangerous if administered incorrectly. The frequency of
these injections can be reduced considerably by the use of
suspensions of crystallites (Schlichtkrull, 1965; Schlichtkrull
et al., 1972). Sustained release of the insulin into the blood
stream is achieved if the crystallites have a narrow size
distribution (Long et al., 1996; Peseta et al., 1989; Reichert
et al., 1995). Currently, insulin crystals are being ﬁltered
through a sequence of sieve trays to ensure such narrow size
distribution (Brange, 1987). Optimization of the crystalliza-
tion procedures to yield crystals of narrow size distribution
could allow complete elimination of the ﬁltering stage. Data
on the thermodynamics of insulin crystallization is a neces-
sary fundamental step in the study of this system (Brange,
1987).
The primary goal of the investigations reported here was
to characterize the thermodynamics of crystallization of in-
sulin. For this, we determine the solubility of insulin at vary-
ing solution composition and temperature. Analyzing the
thermodynamics data, we conclude that the hydrophobic
attraction is a major factor for the crystallization of insulin.
The hydrophobic force was deﬁned in the 1960s as the
interaction between nonpolar molecules or surface patches
that only exists when the nonpolar moieties are submerged in
water (Eisenberg and Kauzmann, 1969; Tanford, 1961). The
free energy of a pair of molecules is lowered when the mol-
ecules are closer because of favorable entropic and enthal-
pic contributions (Chandler, 2002). The entropy increase
stems the destruction of the rigid shell of ordered water
molecules built around nonpolar surfaces in an attempt to
preserve four hydrogen bonds per each water molecule
(Tanford, 1980). With relatively small nonpolar molecules
this entropy effect accounts for the complete thermodynam-
ics of hydrophobicity (Tanford, 1980). It has recently been
pointed out that around larger nonpolar molecules the
number of hydrogen bonds per water molecules cannot be
preserved (Chandler, 2002). As a result, when two nonpolar
surfaces are brought together, the release of the waters
structured around them not only leads to an entropy increase,
but also to an enthalpy loss due to the restoration of four
hydrogen bonds around each of the waters involved
(Chandler, 2002).
Due to this relation between the thermodynamics of in-
termolecular interactions and the structuring of the water
molecules around the certain patches of the protein mo-
lecular surface, we use thermodynamics data to elucidate
the interactions and structuring of the solvent around the
protein molecules (Petsev and Vekilov, 2000; Vekilov et al.,
2002b). Because many proteins are crystallized from so-
lutions containing organic additives (Farnum and Zukoski,
1999; Galkin and Vekilov, 2000; Kulkarni et al., 1999;
Sauter et al., 1999), the effects of these additives on the
protein’s interaction are of interest and are addressed here on
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the example of acetone, a co-solvent sometimes used in in-
sulin crystallization (Harding et al., 1966).
METHODS
Solutions
The protein material used in the experiments was porcine insulin from
Sigma. To prepare stock solutions, the protein was dissolved in 0.02 M HCl
at a ratio of ;15 mg insulin per 1 ml HCl and then ﬁltered using Millipore
Ultrafree-CL microcentrifuge ﬁlters with molecular weight cutoff of 30 kDa
to remove solid residue. The concentration of the solution was determined at
various dilutions at 280 nm in a spectrophotometer using an extinction
coefﬁcient of 1.04 ml mg1 cm1 (Pace et al., 1995). The blank used to
calibrate the spectrophotometer was pure 0.02 M HCl. These solutions were
stored at 48C and disposed of after ;3 weeks.
To an aliquot of insulin solution in 0.02 M HCl were added, in the order
listed, 0.10 M zinc chloride (Sigma, St. Louis, MO), 0.2 M trisodium citrate
(Fisher, Fairlawn, NJ), and neat acetone (SPLC-grade, Fisher). Thus, the
ﬁnal concentrations of the components in the crystallizing solutions were:
insulin, between 0.75 and 5 mg ml1; ZnCl2, 0.005 M; trisodium citrate,
0.05 M; and acetone, between 0 and 20%, in 0.02 M HCl (Peterson, 1959;
Schlichtkrull, 1956, 1957; Smith, 1995).
Solvent samples without insulin were prepared in the same way as the
crystallizing solutions substituting 0.02 M HCl in place of the insulin stock
solution. Approximately 15 ml were prepared in advance. These solutions
were quickly sealed to prevent evaporation of volatile species, labeled, and
stored in the refrigerator.
Determination of the protein concentration
We implemented a procedure for determination of the protein concentration
in solutions containing acetone. Typically, the protein concentration is
evaluated from the optical density at a wavelength of 280 nm using Beer’s
law (Harris, 2001). This method is not applicable in solutions containing
acetone because acetone absorbs light at this wavelength, Fig. 1. To
circumvent this difﬁculty, we employed the Bradford reagent (Bradford,
1976; Reichert et al., 1995), whose complex with insulin has signiﬁcant
optical density at a higher wavelength at which acetone has no absorbance,
see Fig. 1.
Calibration curves were established for each acetone concentration. For
each calibration curve, we prepared six solutions with concentrations of
insulin in the approximate range 0.2 – 1.2 mg ml1. A 50-ml solution sample
was added to 500 ml of Bradford Reagent (Bradford, 1976; Reichert et al.,
1995), mixed, sealed, and allowed to sit for 20 min. Tests, illustrated in
Fig. 2, revealed that 20 min was the optimal delay for stable optical density
readings. The samples were then placed in clean cuvettes and loaded into the
spectrophotometer, calibrated with 500 ml Bradford Reagent 1 50 ml 0.02
M HCl. Absorbance readings were taken at 595 nm; two readings for each
insulin concentration were averaged.
The calibration curves, i.e., the dependencies of the optical density with
the Bradford Reagent on the protein concentration of the samples, are shown
in Fig. 3. These linear relationships were then used to relate protein
concentration to optical density at 595 nm. Two additional solutions with
0% acetone and two with 15% acetone were used to check the accuracy of
the respective calibrations.
In the course of solubility determinations, protein concentrations of
solution samples were determined by adding 500 ml Bradford Reagent to
50 ml of the tested solution. The samples were covered, mixed, allowed to sit
for 20 min, and their optical density was read. The protein concentration
was determined from the calibration curves discussed above.
Determination of the temperature dependence
of the solubility
The solubility of insulin crystal solutions was determined using a batch
technique (Fischel-Ghodsian, 1988). For each acetone concentration, 18
vials were carefully labeled, ﬁlled with 700 ml solvent solution, and sep-
arated into six groups, kept at 48C, 108C, 158C, 208C, 258C, and 308C,
respectively. A refrigerator was used to maintain 48C, water circulators for
108C, 158C, and 208C, and two incubators were kept at 258C and 308C,
respectively. The vials in the water circulators were tightly sealed and ﬂoated
on the water surface by attaching pieces of Styrofoam to their tops in a way
that ensured that the entire solution volume was submerged.
Independently, a suspension of crystals in solution was prepared by
keeping a 200-ml crystallizing solution at 48C. Each day, after gentle stirring
to ensure that the crystals are suspended in the solution volume, an aliquot
containing crystals was taken and released into the vials kept at the different
temperatures. On the next day, a small sample was taken from the bottom of
FIGURE 2 Changes of the optical density at l ¼ 595 nm with time in
insulin solutions containing Bradford Reagent added at t ¼ 0 min. Vertical
bars mark time interval of steady optical density between ;8 and 50 min.
Insulin solution used contains 500 ml Bradford Reagent and 50 ml 15%
acetone.
FIGURE 1 Spectrophotometry scans of insulin and acetone solutions in
the HCL/ZnCl2/citrate mixture used in the crystallization experiments and
a spectrum of insulin in the presence of the Bradford reagent. Calibration
with deionized water. The wavelengths 280 and 595 nm are marked with
arrows.
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the vials and observed under a microscope. A typical picture of the
rhombohedral crystals seen with this procedure is shown in Fig. 4. If no
crystals were detected, it was assumed that all of the crystals had dissolved
and more were added. In some cases, after extended lengths of time, if at T[
258C or at Cac$ 10% the microscopic observations revealed the presence of
a noncrystalline precipitate, these solutions were discarded. In the vials, in
which undissolved crystals were found, the protein concentration of the
supernatant was determined using the procedures discussed above. For this,
after ;30 min of rest to ensure sedimentation of the crystallites, 50 ml
samples was taken from the top of the vials.
This procedure was followed for each sample until the concentrations
were steady for three consecutive days. Examples of the concentration
evolutions in the supernatant in contact with crystallites are shown in Fig. 5.
In most cases, the crystals added to a solution sample kept at a certain
temperature dissolved over time until solubility was reached. This led to
increasing concentration in the monitored supernatant until saturation was
reached. In some cases, samples of the solutions at 48C were taken before
equilibration at that temperature. As a result, the solution concentration was
signiﬁcantly higher than the solubility. The addition of an aliquot of this
solution to a solution kept at higher temperatures brought the concentration of
the recipient solution to a value above the solubility at the respective T. The
respective evolution curves in Fig. 5 b show a decrease of the concentration
with time. Furthermore, since the presence of detectable crystals was used as
a criterion to decide whether to add new crystals to a solution, sometimes
crystals were added to already saturated solutions and this leads to
nonmonotonic concentration evolution curves, such as those in Fig. 5 a.
Steady concentration values were taken as evidence of equilibrium be-
tween the crystals and solution. The equilibrium concentrations were deter-
mined as averages over three vials of identical composition and history and
over at least three last steady readings for a total of at least nine data
points. For most of the tested conditions the standard deviation determined
from these data points ranged from 4% to 6%.
The equilibrium concentrations were plotted as a function of the tem-
perature at which the solutions were kept (Feeling-Taylor et al., 1999;
Galkin and Vekilov, 2000). This process was repeated for each acetone
concentration. Two runs were performed for 15% acetone to verify the
accuracy and reproducibility of this method.
RESULTS
Solubility
Fig. 6 shows that the solubility of insulin mostly has a normal
dependence on temperature—as temperature increases, so-
lubility increases. The presence of acetone in the solution
affects the solubility as well as its sensitivity to temperature
changes—higher acetone concentrations leads to higher
solubility and to wider concentration variations in response
to temperature. Whereas the solubility with no acetone is in
the range of 0.1–0.2 mg ml1, for 20% acetone it ranges be-
tween ;0.25 and 1.1 mg ml1.
Solutions containing 0 and 5% acetone exhibit a higher
solubility at 48C than at the higher temperatures. For evi-
dence that this higher solubility at 48C at Cac ¼ 0 is not the
result of experimental error, we show in Fig. 7 the concen-
tration evolution curves.
The solubility curve for 5% acetone is so low that the error
in each determination is commensurate with the respective
FIGURE 4 Rhombohedral insulin crystals used in the solubility determi-
nations.
FIGURE 5 Representative time evolution curves of the protein concen-
tration during solubility determinations. Lines are just guides for the eye. (a)
Cac ¼ 15%; equilibrium reached by dissolution of crystals; for discussion of
local maximum at 3–4 days, see text. (b) Cac¼ 10%; equilibrium reached by
the growth of initially added crystals; for discussion see text. Error bars
correspond to the standard deviation of three determinations, as discussed in
text.
FIGURE 3 The concentration calibration curves using Bradford Reagent
for all acetone concentrations used in this work. Error bars correspond to the
standard deviation of several determinations.
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solubility value. Thus, data at 5% acetone are not used to
extract thermodynamic potentials.
Enthalpy and free energy
The standard enthalpy of crystallization (also called the la-
tent heat) DHocryst can be evaluated from the solubility using
the Gibbs-Helmholtz equation (Atkins 1998),
@ lnKcryst
@T
 
P
¼  @ðDG
o
cryst=RTÞ
@T
 
P
¼ DH
o
cryst
RT
2 ; (1)
where Kcryst¼ exp(DGocryst=RT) is the equilibrium constant
for crystallization, T is absolute temperature, DGocryst is the
standard change of Gibbs free energy upon crystallization,
and R ¼ 8.314 J mol1 K1 is the universal gas constant.
The crystallization equilibrium constant Kcryst can be rep-
resented as (Atkins, 1998),
Kcryst ¼ a1e ¼ ge
Ce
C
o
 1
; (2)
where ae is the activity of insulin in solution in equilibrium
with the crystals, ge is the activity coefﬁcient, Ce is the
solubility, and Co ¼ 1 mol kg1 is the concentration of the
solution in the typically chosen standard state. As discussed
in Vekilov and Chernov (2002), the selection of a different
standard state, e.g., 1 mmol kg1, does not affect the values
of DHocryst, whereas the shift in the determined values of
DGocryst and DS
o
cryst are relatively minor and do not affect the
conclusions about the underlying physical processes.
The activity coefﬁcient at equilibrium between crystal and
solution ge, was evaluated from the relationship (Hill, 1986;
Yau et al., 2000),
ln ge ¼ 2B2MinsulinCe: (3)
Although data concerning the second virial coefﬁcient B2 for
insulin are not available, we note that for proteins under
crystallizing conditions B2 is always negative and the
maximum magnitude on record is jB2j ¼ 8 3 104 cm3
mol g2 (George and Wilson, 1994; Guo et al., 1999;
Rosenbaum et al., 1996). Using this value of B2, for Ce\ 1
mg ml1 ¼ 103 g cm3, we get ge ¼ 0.946, i.e., assuming
ge 1 yields at most 6% bias in the values of Kcryst. Since in
solutions containing Zn21, insulin is present as a hexamer
(Blundel et al., 1972), and the hexamers are the building
blocks of the crystals (Yip et al., 1998; Yip and Ward, 1996),
we use the relative molecular mass of the hexamerMinsulin ¼
34,800 g mol1.
Combining Eqs. 1 and 2, with the approximation ge  1,
we get
@ lnðCe=CoÞ
@T
 
P
¼ DH
o
cryst
RT2
or ln
Ce
C
o
 
¼ DH
o
cryst
RT
1 const:
(4)
Thus, DHocryst can be evaluated from the slope of the straight
lines lnCe(T
–1) in Fig. 8, in which the Ce values were
converted to mol kg1 of solvent. Most of the resulting
DHocryst values, plotted in Fig. 9 a are negative, as can be
expected from the normal dependence of the solubility on
temperature. The upper point at 0% acetone indicates high
positive enthalpy and corresponds to the strong decrease in
solubility between 4 and 108C seen in Fig. 6 and Fig. 7.
Because of the large error inherent in the solubility de-
terminations at Cac ¼ 5%, the enthalpy value at this con-
centration was not evaluated from the data, but was
interpolated from the DHocryst values at 0 and 10% acetone.
The veracity of this interpolation was checked by simulating
a lnCe(T
–1) line with the chosen DHocryst and Ce(208C) ¼
0.022 mg ml1. This line is plotted in Fig. 8 and is in good
agreement with the Ce data between 10 and 308C.
Although we cannot evaluate the bias in DHocryst in Fig. 9
a due to the approximation ge 1, we do not expect this bias
to be large. The smallness of the deviation of ge from unity
is mostly due to the low Ce in Eq. 3 and does not imply
an assumption of solution ideality. In support of this conclu-
sion, we note that three determinations of the crystallization
enthalpy of lysozyme: calorimetric, based on Eq. 4, and
based on Eq. 1 with an account for nonideality through
FIGURE 6 The temperature dependence of the solubility Ce of insulin
crystals at ﬁve acetone concentrations. Lack of data points at higher acetone
concentrations and temperatures is due to protein precipitation.
FIGURE 7 Time evolution of protein concentration during a solubility
determination at Cac ¼ 0%. Error bars correspond to the standard deviation
of three determinations.
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a virial-type expression including forth-order concentration
terms, yielded DHocryst values within 10% of one another
(Petsev et al., 2003b).
The value of DHocryst ; 20 kJ mol1 is preserved be-
tween 0 and 10% acetone, whereas at 15% and 20% ace-
tone, DHocryst takes another consistent value of ;– 55 kJ
mol1. The reasons for this transition will be discussed
below.
The standard free energy of crystallization DGocryst was
evaluated from
DG
o
cryst ¼ RT ln ae ﬃ RT lnðCe=CoÞ; (5)
resulting from a combination of Eq. 2 with Kcryst ¼
expðDGocryst/RT) and ge  1. The resulting values of
DGocryst are shown in Fig. 10. Whereas, with the exception of
the 4–108C interval for 0 and 5% acetone, the enthalpy
remains constant within the investigated temperature range,
DGocryst undergoes a linear change. This change is attributable
to the entropy factor TDSocryst in the free energy expression
DGocryst ¼ DHocryst  TDSocryst: (6)
Evaluating DSocryst in Fig. 9 b, we ﬁnd that it jumps and
switches its sign from ;35 J mol1 K1 at the ﬁrst three
acetone concentrations to ;110 J mol1 K1 at Cac ¼ 15
and 20%.
DISCUSSION
The tying up of a protein molecule in a dimer, bigger cluster,
or crystal is accompanied by the loss of its entropy (Hill,
1986; McQuarrie, 1976). This entropy effect, DSprot, consists
of the loss of six (ﬁve for linear molecules) translational and
rotational degrees of freedom, partially balanced by the
newly created vibrational degrees of freedom (Finkelstein
and Janin, 1989; Tidor and Karplus, 1994). Estimates of the
magnitude of the net effect reach as high as –280 J mol1
K1 for the formation of the insulin dimer from two
monomers (Tidor and Karplus, 1994), with a somewhat
broader consensus centered at ;100–120 J mol1 K1
(Fersht, 1999; Finkelstein and Janin, 1989).
In solution, the protein molecule is encased in a shell of
structured water molecules. The traditional viewpoint has
been that this shell is mainly around the hydrophobic patches
on the protein surface (Eisenberg and Kauzmann, 1969). It
has recently been suggested that water, with the participation
of ions of charge opposite to that of the local surface charges,
FIGURE 8 The temperature dependence of the solubility Ce in the
coordinates of the Gibbs-Helmholtz equation ln(C/Co) vs. T
1. Solid lines
are linear ﬁts to data at Cac ¼ 0, 10, 15, and 20%, with slope ¼ DHocryst/R.
The dependence at Cac¼ 0% changes slope, allowing two determinations of
DHocryst. Dashed line is a simulated line through data at Cac ¼ 5%, calculated
as discussed in the text.
FIGURE 9 Variations with acetone concentration of (a) standard
crystallization enthalpy DHocryst and (b) standard entropy change for
crystallization DSocryst. Pairs of points at Cac ¼ 0 correspond to two straight
lines in Fig. 8. Open symbols at Cac¼ 5% are results of DHocryst interpolation
as discussed in the text. The high values of H and S at Cac ¼ 0% step from
the low temperature solubility data at this Cac in Fig. 6.
FIGURE 10 Temperature dependence of the crystallization free energy at
ﬁve acetone concentrations. Linear ﬁts ignore data at 258C for Cac ¼ 15%,
and at 48C for Cac ¼ 0. Dashed line is a simulated line through data at Cac ¼
5%, calculated as discussed in the text.
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forms structures around the polar and charged protein surface
patches (Israelachvili, 1995; Leckband and Israelachvili,
2001; Manciu and Ruckenstein, 2002; Paunov et al., 2001;
Petsev et al., 2000; Petsev and Vekilov, 2000).
The formation of a bond as the protein molecule joins a
cluster or crystal may lead to a release of some of the water
molecules and other solvent species structured at hydropho-
bic and hydrophilic patches. It has been suggested (Tanford,
1980) that the entropy effect of release of one water molecule
is comparable to the entropy change for melting of ice—at
273 K, DSoice ¼ 22 J mol1 K1 (Dunitz, 1994; Eisenberg
and Crothers, 1979; Eisenberg and Kauzmann, 1969).
Similarly, estimates of the entropy loss due to the tying up
of hydration water in crystals have yielded 25–29 J mol1
K1 (Dunitz, 1994). Thus, the release of just a few solvent
molecules may completely compensate for the entropy loss
due to the tying up of the protein molecule, and even render
the net entropy of attachment positive.
These considerations suggest that the total change of
entropy upon crystallization DSocryst divides into two
components—
DS
o
cryst ¼ DSsolvent1DSprot: (7)
The similarity of the value of the DSocryst ¼ 110 J mol1
K1 at high Cac to the entropy effect for tying of one protein
molecule (Fersht, 1999; Finkelstein and Janin, 1989) is the
basis of our assumption that DSocryst at high acetone
concentrations is an indication of the value of DSprot. We
also assume that the entropy of a molecule in crystals grown
at high Cac equals the entropy in crystal grown at low Cac.
Both crystalline forms are rhombohedral. We found no
evidence in literature of differences between these two
forms. We carried out determination of the crystallographic
lattice parameters using the atomic force microscope
(Reviakine et al., 2003). The determinations indicate, with
an accuracy of ;20%, stemming from the 10–12 A˚
resolution of the atomic force microscopy technique in our
hands and the rhombohedral lattice parameter of 49 A˚ (Baker
et al., 1988), that the crystal forms in the presence and
absence of acetone are alike (Reviakine et al., 2003). Al-
though it is possible that similar crystals form in equi-
librium with solutions containing different Cac values which
have different amounts of acetone in intermolecular channels,
we speculate that the chemical potential of an insulin
molecule in the crystal is mostly determined by the in-
termolecular bonds. The similarity of the lattice parameters
allows us to speculate that the intermolecular bonds are
similar, and to assume that mInsulin (crystal, low Cac) 
mInsulin (crystal, high Cac).
On the basis of these assumptions, we evaluate the entropy
effect of the release of the water upon crystallization DSsolvent
from the difference in DSocryst at low and high Cac. Then,
comparing the high value of DSocryst ¼ 350 J mol1 K1 at
Cac ¼ 0, corresponding to crystallization in the temperature
range 4–108C, to the value DSocryst ¼ 110 J mol1 K1 at
Cac ¼ 15 and 20%, get DSsolvent  460 J mol1 K1.
Although higher than the value for DSsolvent at the higher T
values at Cac ¼ 0 and at the other Cac values, this value is
lower than, e.g., for hemoglobin C and apoferritin, for which
it reaches ;600–610 J mol1 K1 (Vekilov et al., 2002a,b;
Yau et al., 2000). Scaling this value with the above DSoice ¼
22 J mol1 K1, we ﬁnd that this value corresponds to the
release of ;20 water molecules.
On the other hand, comparing DSocryst ¼ 35 J mol1 K1 at
the higher T values at Cac¼ 0, and at Cac¼ 5 and 10%, to the
same DSocryst ¼ 110 J mol1 K1 at Cac ¼ 15 and 20%, we
get for DSsolvent ¼ 145 J mol1 K1. Scaling this value with
DSoice, we conclude that approximately six or seven water
molecules are released upon the attachment of an insulin
molecule to a growth site on the crystal surface. Attachment
involves the creation of Z/2 ¼ 4 molecular contacts, where Z
¼ 8 is coordination number of a molecule in the lattice of
rhombohedral crystals, such as insulin. Thus, ;1.5–2 water
molecules are released for the formation of one intermolec-
ular bond and the entropy effect of this release contributes to
the free energy of crystallization. The higher number of re-
leased waters upon crystallization at T ¼ 4 – 108C at Cac ¼
0 might indicate a greater number of hydrophobic contacts
formed upon attachment to a growth site at these temper-
atures. The likely locations of these excess contacts are the
lower and upper rims of the ringlike insulin hexamer—in the
rhombohedral lattice, the hexamer rings are stacked along
a threefold axis passing through the rings’ centers.
The conclusion about the signiﬁcance of the release of
water molecules upon the attachment of an insulin molecule
to a growth site allows us to deﬁne the intermolecular bonds
in insulin crystal as hydrophobic (Dixit et al., 2002;
Eisenberg and Crothers, 1979; Eisenberg and Kauzmann,
1969; Tanford 1961, 1980). The latter conclusion agrees
with analyses based on identifying the hydrophobic surface
patches form the atomic structure of the insulin molecule and
comparing their orientation in the crystalline lattice (Yip
et al., 1998).
The observation of a stepwise transition from DSocryst ¼ 35
J mol1 K1 to DSocryst ¼ 110 J mol1 K1 as acetone
concentration increases from 10 to 15%, corresponds, with
the assumptions discussed above, to a transition of DSsolvent
from 145 J mol1 K1 to zero. This stepwise transition
suggests that the destruction of the water structure around the
insulin molecules requires a threshold acetone concentration.
In this sense, it is akin to a ﬁrst-order phase transition in the
layer surrounding the insulin molecule, with the acetone
concentration as a driving force. The low acetone ‘‘phase’’
could be deﬁned as structured water, replaced by a ‘‘phase’’
consisting of loose water 1 acetone at higher Cac. Note that
this analogy is based on macroscopic thermodynamic data
and is necessarily somewhat superﬁcial. A deeper un-
derstanding of the thermodynamic, kinetic, and structural
aspects of the solvent structures around protein molecules in
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aqueous, partially aqueous, and nonaqueous solutions is re-
quired for a more complete understanding of this and other
features of hydrophobicity.
In accordance with the analogy to a ﬁrst-order phase
transition in the layer surrounding the insulin molecules, the
crystallization enthalpy DHocryst also undergoes a stepwise
change as Cac increases from 10 to 15%. However, one
should not expect to see a shift in DGocryst. DSsolvent and the
corresponding enthalpy represent the total changes of S and
H upon this ‘‘phase transition,’’ rather than the differences in
H and S between the respective two standard states.
Correspondingly, the total change of free energy is zero.
The sign of the enthalpy shift is somewhat unexpected. It
has recently been pointed out (Chandler, 2002) that the
formation of water structures around hydrophobic moieties
may be accompanied by an enthalpy increase if the hydro-
phobic moieties are so large that the water structure cannot
rearrange itself around them without the loss of several
hydrogen bonds (Chandler, 2002). In view of the typical
enthalpies of the O-H–O hydrogen bonds of ;(10–20) kJ
mol1 (Eisenberg and Crothers, 1979), this increase may be
signiﬁcant. If this rationale applies to insulin, one would
expect the crystallization enthalpy at low Cac to include the
enthalpy loss due to the reestablished H-bonds of the water
released upon the formation of the hydrophobic contacts.
Then, jDHocrystj should decrease at higher Cac where the
water structures in solution are broken before crystallization.
In fact, Fig. 8 shows that jDHocrystj increases. This dis-
crepancy suggests that the hydrophobic patches at the sur-
face of the insulin molecule are relatively small so that the
enthalpy gain upon water structuring is low. Thus, the con-
tribution of the enthalpy of water structuring to the shift
in DHocryst with increasing Cac is small and DH
o
cryst at Cac¼ 15
and 20% corresponds to the attachment to a crystal growth
site of a molecule surrounded by a loose layer of water 1
acetone.
The conclusion about the existence of a structured water
layer at the hydrophobic moieties on the insulin surface at
low and zero acetone concentrations and its destruction at
a certain acetone concentration may have consequences for
the kinetics of growth of the insulin crystals. It was recently
shown the kinetics of attachment of solute molecules to
a growth site on the crystal surface for a broad class of
crystals growing from aqueous solutions are limited by the
rate of passage over a barrier due to the water molecules
attached to the protein surface (Petsev et al., 2003a). One
would expect that the removal of structured water molecules
would be slower than the removal of loose and disordered
ones, resulting in respectively slower kinetics of attachment
to the growth sites and crystal growth (Makarov et al., 2000,
2002). This expectation seems to be supported by a recent
determination of the kinetic coefﬁcients for step growth of
insulin crystals at conditions identical to those tested here
(Reviakine et al., 2003). It was found that in the presence of
acetone, the step kinetics coefﬁcient is ;0.5 mm s1—an
order-of-magnitude higher than that in the absence of ace-
tone—and comparable to the kinetic coefﬁcients of many
small-molecule inorganic substances (Chernov, 1989).
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